@article {105,
	title = {What{\textquoteright}s eating you? Pediculus humanus (head louse and body louse)},
	journal = {Cutis},
	volume = {63},
	year = {1999},
	month = {1999},
	pages = {259 - 264},
	abstract = {Head lice remain a common problem worldwide. As resistance to available therapeutic agents can emerge rapidly, there is a need for continued research to find new and better agents. Until better agents are available, clinicians may find that rotational therapy, using different agents, may help to slow the emergence of resistance. Physical modalities, such as mechanical nit and louse removal and occlusive agents to asphyxiate the lice, should not be ignored, especially in light of our limited therapeutic armamentarium. All therapeutic agents are doomed to failure if infestation is allowed to recur. Classmates, playmates, and family members of infested children should be inspected for head lice. Efforts should be directed at fomite control and nit removal. Louse infestation must be addressed as a community-wide problem. Body lice remain important vectors of disease. War, natural disaster, and poverty favor the spread of body lice. As we work to solve these seemingly eternal problems, we must develop better agents to treat infestation and prevent the spread of body lice.},
	keywords = {adult, animals, carbaryl, child, Diagnosis, Differential, Drug Combinations, humans, insecticide, Ivermectin/therapeutic use, Lice Infestations/diagnosis/drug therapy, Lindane/therapeutic use, malathion, Pediculus, Permethrin, Piperonyl Butoxide, Pyrethrum, Research Support, Non-U.S. Gov{\textquoteright}t, Trimethoprim},
	author = {Elston,D. M.}
}
@article {59,
	title = {Efficacy of a reduced application time of Ovide lotion (0.5\% malathion) compared to Nix creme rinse (1\% permethrin) for the treatment of head lice},
	journal = {Pediatric dermatology},
	volume = {21},
	year = {2004},
	note = {JID: 8406799; 0 (Insecticides); 121-75-5 (Malathion); 52645-53-1 (Permethrin); ppublish},
	month = {2004},
	pages = {670 - 674},
	address = {United States},
	abstract = {Our objective was to conduct a randomized, investigator-blinded evaluation of the pediculicidal and ovicidal activity of a reduced application time (20 minutes) of Ovide (0.5\% malathion) compared to Nix (1\% permethrin) in a south Florida population infested with Pediculus humanus capitis. Either Ovide or Nix was applied according to the label instructions. However, Ovide application time was reduced to 20 minutes. At day 8, subjects with live lice were re-treated with the same product and procedure as on day 1. Ovicidal and pediculicidal efficacy were evaluated at days 8 and 15. A subject free of lice and viable eggs at day 15 was considered to be a treatment success. Percent efficacy was calculated using the number of subjects free of lice and viable eggs per total number of subjects treated. We found that a 20-minute application of Ovide was significantly more pediculicidal and ovicidal (98\%) compared to Nix (55\%) at day 15 (p < 0.0001). The percentage of Ovide subjects who required treatment at day 8 was half that of the Nix group. The reinfestation rate was 0\% with Ovide and 33\% with Nix. In conclusion, a 20-minute treatment with Ovide, instead of the approved 8- to 12-hour application, cured 40 of 41 subjects (98\%), demonstrating superior efficacy to Nix. The poor efficacy of Nix confirms the resistance of head lice to permethrin in south Florida.},
	keywords = {adolescent, adult, Aged, animals, child, Comparative Study, Dose-Response, Florida, humans, insecticide, Lice Infestations/drug therapy, malathion, Middle Aged, Pediculus, Permethrin, Research Support, Non-U.S. Gov{\textquoteright}t, scalp dermatoses, Single-Blind Method, Treatment Outcome},
	isbn = {0736-8046},
	author = {Meinking,Terri Lynn and Vicaria,M. and Eyerdam,D. H. and Villar,M. E. and Reyna,S. and Suarez,G.}
}
